The Nasdaq Stock Market ended the session with Arena Pharmaceuticals jumping 2.53% to $70.62 on Thursday, following yesterday’s downward trend. The Nasdaq Stock Market rose 0.54% to $12,405.80, following yesterday’s downward trend on what was a somewhat positive trend exchanging session today.
Arena Pharmaceuticals today’s close was $70.62, 27.71% under its 52-week high of $90.19.
Arena Pharmaceuticals’s Sales
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s Stock Top and Bottom Yearly Value
Arena Pharmaceuticals’s stock is valued at $70.62 at 17:35 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.
Arena Pharmaceuticals’s Moving Average
Arena Pharmaceuticals’s value is under its 50-day moving average of $73.43 and higher than its 200-day moving average of $69.02.